We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
+17.14%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$350M
AUM Growth
+$51.5M
Cap. Flow
+$10.4M
Cap. Flow %
2.97%
Top 10 Hldgs %
68.11%
Holding
35
New
7
Increased
16
Reduced
6
Closed
5

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$10.1M
2
SRCL
Stericycle Inc
SRCL
+$7.66M
3
HOLX
Hologic
HOLX
+$7.07M
4
RIGL icon
Rigel Pharmaceuticals
RIGL
+$5.78M
5
MDRX
Veradigm Inc. Common Stock
MDRX
+$4.76M

Top Sells

Rank Stock Value
1
NVCR icon
NovoCure
NVCR
+$18.5M
2
XRAY icon
Dentsply Sirona
XRAY
+$12M
3
MDT icon
Medtronic
MDT
+$5.92M
4
VSI
Vitamin Shoppe Inc.
VSI
+$3.35M
5
SIEN
Sientra, Inc.
SIEN
+$2.44M

Sector Composition

Rank Sector Weight
1 Healthcare 88.33%
2 Industrials 6.2%
3 Consumer Discretionary 2.7%
4 Communication Services 0.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OEF icon
26
PUT
iShares S&P 100 ETF
OEF
$20.1B
$539K 0.15%
+7,000
New +$885K
GILD icon
27
CALL
Gilead Sciences
GILD
$162B
$340K 0.1%
+2,500
New +$189K
SPY icon
28
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$294K 0.08%
1,500
-4,500
-75% -$1.28M
AMGN icon
29
PUT
Amgen
AMGN
$208B
$197K 0.06%
+200
New +$39.4K
MDCO
30
PUT
DELISTED
Medicines Co
MDCO
$72K 0.02%
+2,000
New +$75.4K
HSIC icon
31
PUT
Henry Schein
HSIC
$9.77B
– –
-1,275
Closed -$425K
XRAY icon
32
Dentsply Sirona
XRAY
$2.68B
– –
-275,000
Closed -$12M
PDCO
33
PUT
DELISTED
Patterson Companies, Inc.
PDCO
– –
-1,630
Closed -$469K
SIEN
34
DELISTED
Sientra, Inc.
SIEN
– –
-12,500
Closed -$2.44M
LMNX
35
DELISTED
Luminex Corp
LMNX
– –
-79,089
Closed -$2.33M
1
2

Similar funds

SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

Tamarack Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, Tamarack Advisers held 35 positions worth $350M, up 17% from $299M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Tamarack Advisers's Q3 2018 filing shows 7 new, 16 increased, 6 reduced and 5 closed positions. Its largest new stake was Glaukos: 75,000 shares worth $4.87M. The largest sale was NovoCure, an estimated $18.5M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 89% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Tamarack Advisers's largest Q3 2018 buy was Glaukos: 75,000 shares worth $4.87M.
  • Tamarack Advisers added most to Labcorp in Q3 2018, an estimated $10.1M increase.
  • Tamarack Advisers's biggest Q3 2018 reduction was NovoCure, cutting an estimated $18.5M.
  • Tamarack Advisers fully exited Dentsply Sirona in Q3 2018, selling an estimated $12M.
  • Tamarack Advisers's ten largest holdings make up 68% of its $350M portfolio in Q3 2018.
  • Tamarack Advisers opened 7 new positions and closed 5 in Q3 2018.
  • Tamarack Advisers's portfolio value rose 17% quarter-over-quarter to $350M.

Based on Tamarack Advisers's 13F filing for Q3 2018, filed 13 Nov 2018.